This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vega, G. L. Articles by Grundy, S. M. Search for Related Content PubMed PubMed Citation Articles by Vega, G. L. Articles by Grundy, S. M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Cholesterol

Circulation, Vol 84, 118-128, Copyright © 1991 by American Heart Association

ARTICLES

Metabolic basis of primary hypercholesterolemia

GL Vega, MA Denke and SM Grundy
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9052.

BACKGROUND. Hypercholesterolemia is a well-established risk factor for coronary heart disease. However, the mechanisms underlying hypercholesterolemia, elevated low density lipoprotein (LDL) in particular, are not well understood. To determine these mechanisms, we studied LDL kinetics in a group of men with primary hypercholesterolemia. METHODS AND RESULTS. LDL kinetics in 134 middle- aged men with high-risk levels of LDL cholesterol (more than 160 mg/dl) were compared with kinetics in 16 men with borderline high-risk levels of LDL cholesterol (120-159 mg/dl) and 14 men with heterozygous familial hypercholesterolemia (FH). Patients with primary hypercholesterolemia (non-FH) were further divided into moderate hypercholesterolemia (LDL cholesterol, 160-210 mg/dl; n = 108) and severe hypercholesterolemia groups (LDL cholesterol, more than 210 mg/dl; n = 26). Four factors contributed to increasing LDL cholesterol concentrations above the borderline range to moderately elevated levels: 37 patients had no increase in LDL apolipoprotein (apo) B levels but had abnormally high LDL cholesterol-to-apo B ratios; 14 patients had very low fractional catabolic rates (FCRs) for LDL, similar to FH patients; 35 patients had FCRs for LDL in the borderline range but high production rates for LDL; and 22 patients had a high flux of LDL (high production rates and high FCRs). In general, patients with severe hypercholesterolemia resembled those with moderate LDL elevations, except that their LDL particles were enriched with cholesterol. CONCLUSIONS. Data from the present study reveal that there are several distinct patterns of LDL metabolism responsible for primary hypercholesterolemia. These patterns can serve as the basis for further investigation to determine the molecular defects responsible for each pattern.

This article has been cited by other articles:

				References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]

				K. G. Parhofer, P. H. R. Barrett, T. Demant, and P. Schwandt Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B J. Lipid Res., October 1, 2000; 41(10): 1596 - 1603. [Abstract] [Full Text]

				C. J. Packard and J. Shepherd Lipoprotein Heterogeneity and Apolipoprotein B Metabolism Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3542 - 3556. [Abstract] [Full Text]

				E. A. Fisher, M. Zhou, D. M. Mitchell, X. Wu, S. Omura, H. Wang, A. L. Goldberg, and H. N. Ginsberg The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70 J. Biol. Chem., August 15, 1997; 272(33): 20427 - 20434. [Abstract] [Full Text] [PDF]

				J. R. Schaefer, H. Scharnagl, M. W. Baumstark, H. Schweer, L. A. Zech, H. Seyberth, K. Winkler, A. Steinmetz, and W. Marz Homozygous Familial Defective Apolipoprotein B-100: Enhanced Removal of Apolipoprotein E–Containing VLDLs and Decreased Production of LDLs Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 348 - 353. [Abstract] [Full Text]

				F. Benoist and T. Grand-Perret ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid Pools Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1229 - 1235. [Abstract] [Full Text]

				G. L. Vega and S. M. Grundy Hypercholesterolemia With Cholesterol-Enriched LDL and Normal Levels of LDL–Apolipoprotein B : Effects of the Step I Diet and Bile Acid Sequestrants on the Cholesterol Content of LDL Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 517 - 522. [Abstract] [Full Text]

				L. L. Rudel, J. S. Parks, and J. K. Sawyer Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2101 - 2110. [Abstract] [Full Text]

				F. Tato, G. L. Vega, A. R. Tall, and S. M. Grundy Relation Between Cholesterol Ester Transfer Protein Activities and Lipoprotein Cholesterol in Patients With Hypercholesterolemia and Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 112 - 120. [Abstract] [Full Text]

				M. A. Denke and S. M. Grundy Individual Responses to a Cholesterol-Lowering Diet in 50 Men With Moderate Hypercholesterolemia Arch Intern Med, February 14, 1994; 154(3): 317 - 325. [Abstract] [PDF]

				M. Arca, G. L. Vega, and S. M. Grundy Hypercholesterolemia in Postmenopausal Women: Metabolic Defects and Response to Low-Dose Lovastatin JAMA, February 9, 1994; 271(6): 453 - 459. [Abstract] [PDF]